Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve 1. The Unaudited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gennex Laboratories Limited has informed stock exchanges that its Board of Directors will meet on Friday, November 14, 2025 at 04:00 PM. The key items on the agenda are: (1) consideration and adoption of the Unaudited Financial Statements (both standalone and consolidated) for the quarter and half-year ended September 30, 2025, and (2) consideration of the Limited Review Reports from the Statutory Auditor on these financial statements. Other routine business items may also be discussed. The company's trading window, which has been closed since October 1, 2025 in line with insider trading norms, will reopen 48 hours after the results are declared.
This is a routine regulatory intimation ahead of the Q2/H1 FY26 earnings announcement on November 14. Shareholders should watch for the actual results on that date, as the filing itself does not contain any financial figures or operational updates. No immediate material impact on the stock is expected from this notice alone.